-+ 0.00%
-+ 0.00%
-+ 0.00%

Entero Therapeutics' Grid AI Executes LOI With Hyperscaler AI Data-Center Developer To Deploy Grid AI's Power-Cluster Optimization And Orchestration Platform

Benzinga·11/19/2025 13:49:53
Listen to the news

Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its subsidiary Grid AI has executed a Letter of Intent (LOI) with a stealth-mode hyperscaler artificial intelligence (AI) data-center developer to deploy Grid AI's advanced power-cluster optimization and orchestration platform at the customer's first large-scale AI campus. The campus-expected to be among the more sophisticated AI-ready digital-infrastructure sites in development-will be located in the ERCOT market in Texas.

The LOI represents Grid AI's first hyperscaler agreement and marks a major milestone in Entero's strategy to build the leading global platform for AI-driven power orchestration across next-generation data-center campuses. The definitive commercial contract is expected to be executed in early Q1 2026.

The stealth mode customer's initial Texas campus is scheduled to begin generating revenue for Grid AI in Q3 2026 with approximately $8 million in annual revenue in 2027, scaling to over $50 million in 2029, with multiple additional campuses already in the customer's development pipeline.